Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Lotus Eye Hospital And Institute Ltd - 532998 - Outcome Of Board Meeting Held On November14th 2022

 In terms of Regulation 30 read with Part A Schedule III of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015, we wish to inform you that the Board of Directors of the Company at its meeting held onNovember 14th2022 has transacted the following business: Approved unaudited standalone results for the quarter and period ended September 30, 2022. The Board meeting commenced by 04:30 P.M and ended 07:05 by P.M
14-11-2022
Bigul

Lotus Eye Hospital And Institute Ltd - 532998 - Board Meeting Intimation for Intimation Of Board Meeting

 Lotus Eye Hospital And Institute Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2022 ,inter alia, to consider and approve Pursuant to Regulation 29 and other applicable provisions of the SEBI (LODR) Regulations 2015, we wish to inform you that the Board of Directors of the company will be meeting on Monday, November 14,2022 inter-alia to consider the following: - 1. Unaudited Standalone Financial Results of the company for the quarter and year ended September 30, 2022. Further, with reference to our earlier intimation September 29 2022, we wish to inform that, in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Code of Conduct for Insiders of the Company, the trading window will re-open from 17th November 2022 onwards
05-11-2022
Bigul

Lotus Eye Hospital And Institute Ltd - 532998 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Based on the confirmation received from S.K.D.C. Consultants Limited, Registrar and Transfer Agent of the company, we hereby certify that the securities received for dematerialization have been mutilated and cancelled after due verification and the name of the depository has been substituted in our records as the registered owner within 15 days of receipt of certificate of security and the details are furnished to the stock exchanges. Further, we, certify that the securities which were dematerialized are listed on the Stock Exchanges where the earlier issued securities are listed. . We request you to take this information on record
10-10-2022
Bigul

Lotus Eye Hospital And Institute Ltd - 532998 - Closure of Trading Window

 This is to inform you that as per the SEBI (Prohibition of Insider trading ) regulations 2015 read with BSE Circular Ref No LIST/COMP/01/2019-20 and as per the terms of Code of Internal Procedures and conduct for regulating Monitoring and Reporting of Trading by Insider''s of the company, the trading window for dealing in the Company shares will remain closed from Saturday, October 1st , 2022 till the end of 48 hours after declaration of audited financial results for the quarter ending on 30th September 2022 for specified designated persons as defined in the code. The same has been informed to the Directors and designated persons of the Company The date of Board Meeting for declaration of the financial results of the Company for the quarter ended September 30th 2022 will be intimated in the due course.
29-09-2022
Bigul

Lotus Eye Hospital And Institute Ltd - 532998 - Appointment Of Statutory Auditor For Second Term Of 5 Years

 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) 2015 read with Section 139(2) of Companies Act 2013 read with Rule 3 of Companies (Audit and Auditors) Rules 2014 M/S. Anbarasu and Jalapathi Associates, Chartered Accountants Coimbatore (ICAI Firm Regn.No 010795S) are appointed as the statutory auditors of Lotus Eye Hospital and Institute Limited for a second term of 5 years from the conclusion of 25th Annual General Meeting till the 30th Annual General Meeting. The appointment of M/S Anbarasu and Jalapathi Associates, Chartered Accountants was recommended by the Board of Directors at their meeting held on 25th May 2022.
23-09-2022
Bigul

Lotus Eye Hospital And Institute Ltd - 532998 - Approval Of Final Dividend

 We are pleased to inform that the Final dividend recommended by the Board of Directors in its meeting held on 25.05.2022 has been approved by the Shareholders in the 25thAnnual General meeting held on Thursday 22nd September 2022. The Final Dividend shall be disbursed within 30 days of the Annual General Meeting to all those shareholders whose name appears in the Register of Beneficial owners maintained by CDSL and NSDL as on 10th September 2022.
23-09-2022
Bigul

Lotus Eye Hospital And Institute Ltd - 532998 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

 Voting results of 25th Annual General Meeting
23-09-2022
Bigul

Lotus Eye Hospital And Institute Ltd - 532998 - Shareholder Meeting / Postal Ballot-Outcome of AGM

 Proceedings of 25th Annual General Meeting
23-09-2022
Bigul

Lotus Eye Hospital And Institute Ltd - 532998 - Corrigendum To Annual Report

 The change in the annual report is mentioned in the announcement
14-09-2022
Bigul

Lotus Eye Hospital And Institute Ltd - 532998 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to Section 108 of Companies Act 2013 read with Rule 20(4)(v) of The Companies Management and Administration) Rules 2014 We hereby attach the notice to shareholders by way of Newspaper Advertisement published on August 29th 2022 in Tamil Murasu (Coimbatore Edition) and Business Standard (All India Edition) informing the shareholders all requisite details pertaining to Voting Through Electronic Means.
01-09-2022
Next Page
Close

Let's Open Free Demat Account